Based on these preliminary results the Executive Board expects the consolidated result for the financial year 2021 to exceed the forecast published at the beginning of the year by approximately 20%. It therefore rescinds the previous guidance and increases the full year net profit target from 29 mm to approximately 35 mm EUR and the EPS target from 1.40 EUR to approximately 1.70 EUR. Sales Revenues are expected to remain at the previous year’s level of around 180 mm EUR.
The complete figures for the first half year 2021 will be published on 12 August 2021.
Eckert & Ziegler Strahlen- und Medizintechnik AG
Telefon: +49 (30) 941084-0
Telefax: +49 (30) 941084-112
Telefon: +49 (30) 941084-138
Fax: +49 (30) 941084-112